These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12893005)

  • 1. 4-hydroxynonenal and transforming growth factor-beta1 expression in colon cancer.
    Zanetti D; Poli G; Vizio B; Zingaro B; Chiarpotto E; Biasi F
    Mol Aspects Med; 2003; 24(4-5):273-80. PubMed ID: 12893005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression.
    Biasi F; Tessitore L; Zanetti D; Cutrin JC; Zingaro B; Chiarpotto E; Zarkovic N; Serviddio G; Poli G
    Gut; 2002 Mar; 50(3):361-7. PubMed ID: 11839715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-hydroxynonenal and TGF-beta1 concur in inducing antiproliferative effects on the CaCo-2 human colon adenocarcinoma cell line.
    Vizio B; Poli G; Chiarpotto E; Biasi F
    Biofactors; 2005; 24(1-4):237-46. PubMed ID: 16403984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Jun N-terminal kinase upregulation as a key event in the proapoptotic interaction between transforming growth factor-beta1 and 4-hydroxynonenal in colon mucosa.
    Biasi F; Vizio B; Mascia C; Gaia E; Zarkovic N; Chiarpotto E; Leonarduzzi G; Poli G
    Free Radic Biol Med; 2006 Aug; 41(3):443-54. PubMed ID: 16843825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
    Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB
    Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of transforming growth factor beta1 and its type II receptor in mouse colon tumors induced by azoxymethane.
    Wang QS; Guda K; Papanikolaou A; Dong M; Rosenberg DW
    Int J Oncol; 2000 Sep; 17(3):551-8. PubMed ID: 10938397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.
    Kang Y; Prentice MA; Mariano JM; Davarya S; Linnoila RI; Moody TW; Wakefield LM; Jakowlew SB
    Exp Lung Res; 2000 Dec; 26(8):685-707. PubMed ID: 11195465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
    Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
    Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB; Moody TW; You L; Mariano JM
    Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High tumor grade in salivary gland mucoepidermoid carcinomas and loss of expression of transforming growth factor beta receptor type II.
    Dillard DG; Muller S; Cohen C; Bloch D; Del Gaudio JM; Gal AA
    Arch Otolaryngol Head Neck Surg; 2001 Jun; 127(6):683-6. PubMed ID: 11405868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3).
    Chen A; Davis BH; Sitrin MD; Brasitus TA; Bissonnette M
    Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G864-74. PubMed ID: 12223346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
    Shariat SF; Menesses-Diaz A; Kim IY; Muramoto M; Wheeler TM; Slawin KM
    Urology; 2004 Jun; 63(6):1191-7. PubMed ID: 15183988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative effect of a vitamin D3 analog, EB1089, on HL-60 cells by the induction of TGF-beta receptor.
    Jung CW; Kim ES; Seol JG; Park WH; Lee SJ; Kim BK; Lee YY
    Leuk Res; 1999 Dec; 23(12):1105-12. PubMed ID: 10613355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between endogenous gene expression and growth regulation induced by TGF-beta1 in human gastric cancer cells.
    Li X; Zhang YY; Wang Q; Fu SB
    World J Gastroenterol; 2005 Jan; 11(1):61-8. PubMed ID: 15609398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural changes and alteration in expression of TGF-beta1 and its receptors in prostatic intraepithelial neoplasia (PIN) in the ventral prostate of noble rats.
    Wong YC; Xie W; Tsao SW
    Prostate; 2000 Dec; 45(4):289-98. PubMed ID: 11102953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early castration-induced upregulation of transforming growth factor beta1 and its receptors is associated with tumor cell apoptosis and a major decline in serum prostate-specific antigen in prostate cancer patients.
    Wikström P; Westin P; Stattin P; Damber JE; Bergh A
    Prostate; 1999 Mar; 38(4):268-77. PubMed ID: 10075006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.
    Picon A; Gold LI; Wang J; Cohen A; Friedman E
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):497-504. PubMed ID: 9641494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.